Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Herpes Zoster × Vaccines × Clear all

Phase

Phase 3 2 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 3 Breast Neoplasms 3 Papillomavirus Infections 2 Melanoma 2 Lung Neoplasms 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Sarcoma 1 Prostatic Neoplasms 1 Neuroblastoma 1 Neoplasms, Nerve Tissue 1 NY-ESO-1-expressing Tumors 1 Leukemia, Myeloid, Acute 1 Herpes Zoster 1 Glioma 1 Glioblastoma 1 Diffuse Intrinsic Pontine Glioma 1 Condylomata Acuminata 1 Colonic Neoplasms 1 Carcinoma 1 Anus Neoplasms 1 Adenoviridae Infections 1 Adenocarcinoma 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01460719 2019-03-11

V212-013

Merck Sharp & Dohme LLC

Phase 1 Completed

80 enrolled 13 charts

Herpes Zoster

Data powered by HemOnc (CC BY 4.0) Colophon ⚡